Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/1999
03/16/1999US5882926 Nucleic acid hybridization probes; genetic engineering; gene expression; diagnosing genetic disorders
03/16/1999US5882925 Cdna contained in plasmids, amino acid sequences and cultures
03/16/1999US5882923 Glial cell line-derived neurotrophic factor regulation of ureteric budding and growth
03/16/1999US5882914 Nucleic acids encoding the hypoxia inducible factor-1
03/16/1999US5882910 Lipid kinase
03/16/1999US5882907 Design of new ribozymes capable of self-catalyzed trans-splicing which are based upon the catalytic core of a group i intron are described
03/16/1999US5882901 Sialylating specified oligosaccharide with sialyltransferase, fucosylating with fucosyltransferase
03/16/1999US5882898 Cells and vectors with polynucleotides
03/16/1999US5882897 yitJ
03/16/1999US5882896 M protein
03/16/1999US5882894 Nucleic acids encoding CR8 polypeptides, vector and transformed cell thereof, and expression thereof
03/16/1999US5882892 Polypeptides and dna(rna) encoding and screening for bactericides
03/16/1999US5882891 Polynucleotide segments
03/16/1999US5882890 Nucleic acid and amino acid sequences of novel regulators of g-protein signaling and to the use of these sequences in the diagnosis, prevention, and treatment of disorders associated with cell proliferation and inflammation
03/16/1999US5882889 Response regulator in a two component signal transduction system
03/16/1999US5882887 Proteins for genetic engineering
03/16/1999US5882885 Polypeptides and polynucleotides
03/16/1999US5882880 Dna sequences and cell progression for cancer treatment
03/16/1999US5882877 Cystic fibrosis treatment; genetic engineering
03/16/1999US5882876 Amino acid sequences in proteins and markers of cancer cells
03/16/1999US5882875 Methods for identifying multidrug resistant tumor cells
03/16/1999US5882871 Saliva binding protein
03/16/1999US5882862 Human radioresistance/cell cycle progression gene
03/16/1999US5882860 Hybridization of nucleic acid derived from cell with polynucleotide; genetic engineering; suppressing gene expression
03/16/1999US5882855 DNA encoding a human dopamine D1 receptor and uses thereof
03/16/1999US5882654 Polyvalent melanoma vaccine
03/16/1999US5882644 Monoclonal antibodies specific for the platelet derived growth factor β receptor and methods of use thereof
03/16/1999US5882643 Identification and characterization of such factors which can play a role in preventing, ameliorating or correcting infections, dysfunctions or diseases. a novel lep gene of streptococcus pneumoniae.
03/16/1999US5882640 Antiallergens
03/16/1999US5882626 Therapy for killing tumor cells using antibodies
03/16/1999CA2244232A1 Novel def
03/16/1999CA2236363A1 Novel compound
03/16/1999CA2108963C Compositions and methods for therapy and prevention of cancer, aids and anemia
03/16/1999CA2090186C Method of treatment of hiv-seropositive individuals with dietary whey proteins
03/16/1999CA2081891C Quinolizinone type compounds
03/16/1999CA2019463C Antibiotics plusbacin
03/16/1999CA2008825C Reg protein
03/16/1999CA1340447C Pipecolic acid-containing peptolides, their preparation and pharmaceutical compositions containing them
03/16/1999CA1340437C Interleukin 2 receptor and applications thereof
03/11/1999WO1999012027A1 Modulators of dna cytosine-5 methyltransferase and methods for use thereof
03/11/1999WO1999011812A1 TUMOR SUPPRESSOR GENE ON HUMAN CHROMOSOME 6q27 AND USES THEREOF
03/11/1999WO1999011809A1 Conjugates that contain the homeodomain of antennapedia
03/11/1999WO1999011798A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
03/11/1999WO1999011796A1 Hnk-1 sulfotransferase and methods of use therefor
03/11/1999WO1999011794A2 New vrk1 kinase
03/11/1999WO1999011793A1 HUMAN actVA-ORF4-LIKE PROTEIN
03/11/1999WO1999011791A2 Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents
03/11/1999WO1999011790A1 Tumor necrosis factor receptor ztnfr-6
03/11/1999WO1999011789A1 Genetic engineering of cells to enhance healing and tissue regeneration
03/11/1999WO1999011788A1 Kringle1
03/11/1999WO1999011786A1 pancpin GENE AND COMPOSITION FOR GENE THERAPY
03/11/1999WO1999011784A1 Proton gated ion channel proteins
03/11/1999WO1999011782A1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof
03/11/1999WO1999011781A1 Recombinant human erythropoietin with advantageous glycosylation profile
03/11/1999WO1999011780A2 Conductine protein and a related agent for diagnosing and treating tumor illnesses
03/11/1999WO1999011778A1 Antisense treatment of pulmonary hypertension
03/11/1999WO1999011759A1 GLUCOSE RESPONSIVE β-CELL LINE
03/11/1999WO1999011753A1 SpoOJ2 OF STAPHYLOCOCCUS AUREUS
03/11/1999WO1999011669A1 Diagnosis, prevention and treatment of diabetes
03/11/1999WO1999011667A1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS
03/11/1999WO1999011666A1 N-terminal modifications of rantes and methods of use
03/11/1999WO1999011665A1 Human thrombopoietin produced by established human cell lines, process for producing the same, and medicinal compositions containing the same
03/11/1999WO1999011663A1 HUMAN DEFENSIN DEF-X, GENE AND DNAc, COMPOSITION CONTAINING SAME AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
03/11/1999WO1999011661A1 Biomolecules comprising an elastomeric peptide
03/11/1999WO1999011659A1 Novel cyclic tetrapeptide derivatives and medicinal use thereof
03/11/1999WO1999011658A1 Meta-benzamidine derivatives as serin protease inhibitors
03/11/1999WO1999011657A1 1-amino-7-isoquinoline derivatives as serine protease inhibitors
03/11/1999WO1999011655A1 Modular protein libraries and methods of preparation
03/11/1999WO1999011653A1 Novel rnase p
03/11/1999WO1999011606A2 Inhibitors of protein tyrosine phosphatase
03/11/1999WO1999011298A2 Reverse phase connective tissue repair composition
03/11/1999WO1999011293A1 50 human secreted proteins
03/11/1999WO1999011292A2 Compositions and methods for treating arthritis utilizing gene therapy
03/11/1999WO1999011291A1 A method of inducing apoptosis in human brain tumor cells using nerve growth factor
03/11/1999WO1999011290A1 Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
03/11/1999WO1999011288A1 Sr-bi antagonists and use thereof as contraceptives and in the treatment of steroidal overproduction
03/11/1999WO1999011287A1 Ligands that modulate differentiation of mesenchymal stem cells
03/11/1999WO1999011283A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
03/11/1999WO1999011282A1 Compositions and methods for contraception in or sterilization of mammals
03/11/1999WO1999011281A1 The use of agents which bind g proteins for treating septic shock
03/11/1999WO1999011280A1 Integrin ligand dissociators
03/11/1999WO1999011278A1 Robinia pseudoacacia lectin and its uses
03/11/1999WO1999011277A1 Kits and methods for alleviation of lower gastrointestinal disorders in a human patient
03/11/1999WO1999011260A1 Combination therapy comprising atorvastatin and an antihypertensive agent
03/11/1999WO1999011196A1 Injectable tissue reconstruction material
03/11/1999WO1998057990A3 Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity
03/11/1999WO1998057986A3 Human preprotachykinin b
03/11/1999WO1998057984A3 Torsin, torsin genes, and methods of use
03/11/1999WO1998056810A3 Lus-1 human protein, its production and use
03/11/1999WO1998055512A3 Smad-interacting polypeptides and their use
03/11/1999WO1998055507A3 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and kinase domain
03/11/1999WO1998054212A3 Human type 3 ryanodine receptor protein and dna molecules coding therefor
03/11/1999WO1998054209A3 Human mast cell function-associated antigen (mafa) and uses thereof
03/11/1999WO1998051354A3 Compositions for morphogen-induced osteogenesis
03/11/1999WO1998049300A3 Truncated vegf-related proteins
03/11/1999WO1998047914A3 Us6 gene from the human cytomegalovirus (hcmv)
03/11/1999WO1998046258A3 Use of chondroitinase in the manufacture of a medicament in the treatment and prevention of mucoid secretions
03/11/1999WO1998042847A3 Papilloma virus main capsid protein and the use thereof in diagnosis, therapy and vaccination
03/11/1999WO1998033509A3 Useful properties of human lactoferrin and variants thereof
03/11/1999DE19812802A1 Human transcription factor EMA
1 ... 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 2551 2552 2553 ... 3163